Comparative Pharmacology
Head-to-head clinical analysis: ANTHELIOS SX versus SHADE UVAGUARD.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ANTHELIOS SX versus SHADE UVAGUARD.
ANTHELIOS SX vs SHADE UVAGUARD
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Sunscreen product containing organic UV filters (e.g., avobenzone, octocrylene) that absorb UV radiation and convert it to heat, and inorganic filters (e.g., titanium dioxide, zinc oxide) that reflect/scatter UV light. Provides broad-spectrum UVA/UVB protection.
SHADE UVAGUARD is a sunscreen product containing chemical UV filters such as avobenzone, octinoxate, and oxybenzone. These organic compounds absorb UV radiation and convert it into heat, preventing DNA damage. Avobenzone absorbs UVA rays, while octinoxate and oxybenzone absorb UVB rays. The combination provides broad-spectrum protection.
Not applicable; topical sunscreen product. Applied liberally to all exposed skin 15 minutes before sun exposure; reapply every 2 hours or after swimming/sweating.
Topical application of 2 mg/cm² to all sun-exposed areas 15 minutes before sun exposure; reapply every 2 hours and after swimming or sweating.
None Documented
None Documented
Terminal half-life: 12 hours (range 10-14). Clinical context: permits twice-daily dosing; prolonged in renal impairment (CrCl <30 mL/min: up to 24 h).
Not applicable (topical, non-systemic); if absorbed, estimated <1 hour.
Renal: 95% (glomerular filtration and active tubular secretion). Biliary/fecal: <5%. Unchanged drug: ~80% in urine.
Renal: <1% unchanged; Biliary/fecal: negligible; Primarily remains on skin surface and is removed via washing or sloughing.
Category C
Category C
Sunscreen
Sunscreen